CRYSTALLINE FORMS OF (R-(R*))-2-(4-FLUOROPHENYL)-BETA, GAMMA-DIHYDROXY-5-(1-METHYLETHYL)-3-PHENYL-4-((PHENYLAMINO)CARBONYL)-1H-PYRROLE-1-HEPT ANOIC ACID CALCIUM SALT (2:1)

World Intellectual Property Organization Patent

APP PUB NO WO-2006011041-A2
SERIAL NO

PCTIB2005002181

Stats

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Novel forms of [R-(R*,R*)]-2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4­[(phenylamino)carbonyl]-1 H-pyrrole-1 -heptanoic acid hemi calcium salt designated Form XX, Form XXI, Form XXII, Form XXIII, Form XXIV, Form XXV, Form XXVI, Form XXVII, Form XXVIII, Form XXIX, and Form XXX, characterized by their X-ray powder diffraction, solid-state NMR, and/or Raman spectroscopy are described, as well as methods for the preparation and pharmaceutical composition of the same, which are useful as agents for treating hyperlipidemia, hypercholesterolemia, osteoporosis, benign prostatic hyperplasia (BPH) and Alzheimer's disease.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • Owner owned or assignment not recorded

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

  • No Inventor to display

Cited Art Landscape

Load Citation